SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (8144)12/29/1998 9:44:00 PM
From: dlc  Read Replies (2) | Respond to of 17367
 
Why is it so difficult to get mortality data out of England to see if death rates have gone down during the trial? I have done numerous web searches and contacted several agencies in England and have gotten no responses. Shouldn't this data be a matter of public record? If anyone out there knows how to go about obtaining this data please tell me how to get it or post the data on this thread. All the other talk on this thread is nice but, in my opinion, not very informative.



To: aknahow who wrote (8144)12/30/1998 12:14:00 AM
From: LarryS  Respond to of 17367
 
XOMA will probably put out a press release
tomorrow, or an update on their FAQ page. Might
include other plans in relation to the move.

Still waiting for the PR notice that states
"No patients issued BPI died during recent
Phase III trial". :-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News